logo

For the Inventor, By the Inventor

La Jolla, CA, United States of America

Pharmacopeia Inc.


USPTO Granted Patents = 101



Trademarks = 1

Forward Citations = 1,405

Loading Chart...
Loading Chart...

223 inventors (with patents filed for the assignee):

goldMedal Ilya Feygin (20 out of 38 patents)

silverMedal Roland Ellwood Dolle (17 out of 81 patents)

bronzeMedal John J Baldwin (16 out of 229 patents)

4.  Ian Henderson (9 out of 12 patents)

5.  Timothee Felix Herpin (9 out of 9 patents)

6.  Gregory L Kirk (9 out of 10 patents)

7.  Lawrence Wayne Dillard (8 out of 64 patents)

8.  Yvonne Class Shimshock (8 out of 8 patents)

9.  Ge Li (7 out of 82 patents)

10.  Tao Guo (7 out of 48 patents)

11.  Ronald J Doll (7 out of 105 patents)

12.  John C Reader (7 out of 16 patents)

13.  Jonathan J Burbaum (7 out of 11 patents)

14.  Michael H Ohlmeyer (7 out of 33 patents)

15.  Michelle Lee Morris (6 out of 11 patents)


Core Competencies:
Heterocyclic Inhibitors
Aspartyl Protease Inhibitors
Cyclin Dependent Kinase Inhibitors
Histamine-3 Receptor Ligands
TNF-Alpha Expression Inhibitors
CXCR3 Antagonist Activity
Purinones
Metabolic Disorders
CXC-Chemokine Receptor Ligands
Antitumor Agents
Combinatorial Chemistry
Fluid Control Technologies

101 patents:

1. 8829036 - Heterocyclic aspartyl protease inhibitors (2014-09-09),
2. 8759352 - 1-(4-ureidobenzoyl)piperazine derivatives (2014-06-24),
3. 8691833 - Heterocyclic aspartyl protease inhibitors (2014-04-08),
4. 8673924 - Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors (2014-03-18),
5. 8513232 - Substituted spirocyclic piperidine derivatives as histamine-3 (H3) receptor ligands (2013-08-20),
6. 8350043 - Azinone and diazinone V3 inhibitors for depression and stress disorders (2013-01-08),
7. 8314091 - N-benzyl,N'-arylcarbonylpiperazine derivatives (2012-11-20),
8. 8288371 - Ortho pyrrolidine, benzyl-substituted heterocycle CCR1 antagonists for autoimmune diseases and inflammation (2012-10-16),
9. 8183252 - Heterocyclic aspartyl protease inhibitors (2012-05-22),
10. 8044040 - N-heterocyclic inhibitors of TNF-alpha expression (2011-10-25),
11. 8017616 - Heterocyclic substituted pyridine compounds with CXCR3 antagonist activity (2011-09-13),
12. 8003624 - Functionally selective ALPHA2C adrenoreceptor agonists (2011-08-23),
13. 7989459 - Purinones and 1H-imidazopyridinones as PKC-theta inhibitors (2011-08-02),
14. 7951803 - 8-heteroarylpurine MNK2 inhibitors for treating metabolic disorders (2011-05-31),
15. 7902199 - Heterocyclic substituted piperazine compounds with CXCR3 antagonist activity (2011-03-08),
Pharmacopeia Inc. is a leading pharmaceutical research company, dedicated to discovering and developing novel therapeutics. With a focus on small molecule drug discovery, we employ innovative approaches and advanced technologies to accelerate the development of life-saving medicines. Our expert team combines deep scientific expertise with state-of-the-art facilities to conduct rigorous research and preclinical studies. At Pharmacopeia Inc., we strive to revolutionize the field of drug discovery, and improve the health and well-being of patients worldwide.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

101 Patents

#6 in La Jolla, CA

#848 in California

#3,606 in US

#7,494 in the World

...
La Jolla, CA, United States of America

Pharmacopeia Inc.

Forward Citations = 1,405

223 inventors:

goldMedal Ilya Feygin (20 out of 38 patents)

silverMedal Roland Ellwood Dolle (17 out of 81 patents)

bronzeMedal John J Baldwin (16 out of 229 patents)

4.  Ian Henderson (9 out of 12 patents)

5.  Timothee Felix Herpin (9 out of 9 patents)

Please report any incorrect information to support@idiyas.com
Loading…